Understanding Ras: 'It ain't over 'til it's over'

Trends in Cell Biology

Volumn 10, Issue 4, 2000, Pages 147-154

  Shields, Janiel M ^a   Pruitt, Kevin ^a   McFall, Aidan ^a   Shaub, Amy ^a   Der, Channing J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; RAS PROTEIN; RHO FACTOR;

CANCER; CARCINOGENESIS; CELL ACTIVATION; CELL INVASION; CELL TRANSFORMATION; ENZYME ACTIVITY; HUMAN; MUTATION; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 0034175984     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(00)01740-2     Document Type: Review

References (55)

1. 1 Feig, L.A. et al. (1996) Evidence for a Ras/Ral signaling cascade. Trends Biochem. Sci. 21, 438-441
2. 2 Katz, M.E. and McCormick, F. (1997) Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7, 75-79
3. 3 Downward, J. (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10, 262-267
4. 4 Campbell, S.L. et al. (1998) Increasing complexity of Ras signaling. Oncogene 17, 1395-1413
5. 5 Zohn, I.M. et al. (1998) Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene 17, 1415-1438
6. 6 Wolthuis, R.M. and Bos, J.L. (1999) Ras caught in another affair: the exchange factors for Ral. Curr. Opin. Genet. Dev. 9, 112-117
7. 7 Magee, T. and Marshall, C. (1999) New insights into the interaction of Ras with the plasma membrane. Cell 98, 9-12
8. 8 Marshall, C. (1999) How do small GTPase signal transduction pathways regulate cell cycle entry? Curr. Opin. Cell Biol. 11, 732-736
9. 9 Cox, A.D. and Der, C.J. (1997) Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? Biochim. Biophys. Acta 1333, F51-F71
10. 10 Oliff, A. (1999) Farnesyltransferase inhibitors: targeting the molecular basis of cancer. Biochim. Biophys. Acta 1423, C19-C30
11. 11 Khwaja, A. (1999) Akt is more than just a Bad kinase. Nature 401, 33-34
12. 12 Irani, K. et al. (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275, 1649-1652
13. 13 Romashkova, J.A. and Makarov, S.S. (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86-90
14. 14 Ozes, O.N. et al. (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85
15. 15 Mayo, M.W. et al. (1997) Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278, 1812-1815
16. 16 Frisch, S.M. et al. (1996) Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134, 793-799
17. 17 Khwaja, A. et al. (1997) Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16, 2783-2793
18. 18 Zhu, J. et al. (1998) Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12, 2997-3007
19. 19 Lin, A.W. et al. (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008-3019
20. 20 Ramocki, M.B. et al. (1997) Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis. Mol. Cell. Biol. 17, 3547-3555
21. 21 Gille, H. and Downward, J. (1999) Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem. 274, 22033-22040
22. 22 Van Aelst, L. and D'Souza-Schorey, C. (1997) Rho GTPases and signaling networks. Genes Dev. 11, 2295-2322
23. 23 Nimnual, A.S. et al. (1998) Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science 279, 560-563
24. 24 Fan, W.T. et al. (1998) The exchange factor Ras-GRF2 activates Ras-dependent and Rac-dependent mitogen-activated protein kinase pathways. Curr. Biol. 8, 935-938
25. 25 Scita, G. et al. (1999) EPS8 and E3B1 transduce signals from Ras to Rac. Nature 401, 290-293
26. 26 Olson, M.F. et al. (1998) Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394, 295-299
27. 27 Izawa, I. et al. (1998) Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation. Oncogene 17, 2863-2871
28. 28 Sahai, E. et al. (1999) Transformation mediated by RhoA requires activity of ROCK kinases. Curr. Biol. 9, 136-145
29. 29 Nobes, C.D. et al. (1998) A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion. J. Cell Biol. 141, 187-197
30. 30 Guasch, R.M. et al. (1998) RhoE regulates actin cytoskeleton organization and cell migration. Mol. Cell. Biol. 18, 4761-4771
31. 31 Bos, J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689
32. 32 Clark, G.J. and Der, C.J. (1993) Oncogenic activation of ras proteins. In GTPases in Biology I (Dickey, B.F. and Birnbaumer, L., eds), pp. 259-288, Springer-Verlag
33. 33 Kinch, M.S. et al. (1995) Tyrosine phosphorylation regulates the adhesions of Ras-transformed breast epithelia. J. Cell Biol. 130, 461-471
34. 34 Khosravi-Far, R. et al. (1996) Oncogenic Ras activation of Raf/MAP kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol. 16, 3923-3933
35. 35 Oldham, S.M. et al. (1996) Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 93, 6924-6928
36. 36 Oldham, S.M. et al. (1998) Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade. Oncogene 16, 2565-2573
37. 37 Gire, V. et al. (1999) Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras. Oncogene 18, 4819-4832
38. 38 Goi, T. et al. (1999) Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth. Mol. Cell. Biol. 19, 1731-1741
39. 39 Kauffmann-Zeh, A. et al. (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385, 544-548
40. 40 Plattner, R. et al. (1999) Contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells. Oncogene 18, 1807-1817
41. 41 Yip-Schneider, M.T. et al. (1999) Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression. Int. J. Oncol. 15, 271-279
42. 42 Sebolt-Leopold, J.S. et al. (1999) Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5, 810-816
43. 43 Genot, E. et al. (1998) p21 ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes. Oncogene 17, 1731-1738
44. 44 Klausner, R.D. (1999) Studying cancer in the mouse. Oncogene 18, 5249-5252
45. INK4a. Cell 88, 593-602
46. 46 Burns, J.S. et al. (1992) Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression. Mol. Carcinog. 6, 129-139
47. 47 Hahn, W.C. et al. (1999) Creation of human tumour cells with defined genetic elements. Nature 400, 464-468
48. 48 Morales, C.P. et al. (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21, 115-118
49. 49 Johnson, L. et al. (1997) K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11, 2468-2481
50. 50 Choy, E. et al. (1999) Endomembrane trafficking of ras: the CMX motif targets proteins to the ER and Golgi. Cell 98, 69-80
51. 51 Roy, S. et al. (1999) Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat. Cell Biol. 1, 98-105
52. 52 Feig, L.A. (1999) Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPase. Nat. Cell Biol. 1, E25-E27
53. 53 Fiordalisi, J.J. et al. Mammalian expression vectors for ras family proteins: generation and use of expression constructs to analyse Ras family function. Methods Enzymol. (in press)
54. 54 Joneson, T. and Bar-Sagi, D. (1999) Suppression of Ras-induced apoptosis by the Rac GTPase. Mol. Cell. Biol. 19, 5892-5901
55. 55 Taylor, S.J. and Shalloway, D. (1996) Cell cycle-dependent activation of Ras. Curr. Biol. 6, 1621-1627